Literature DB >> 29445586

Stressed Out - Therapeutic Implications of ER Stress Related Cancer Research.

Randal Riha1, Pooja Gupta-Saraf1, Payel Bhanja1, Samyak Badkul1, Subhrajit Saha1,2.   

Abstract

The unfolded protein response (UPR) is an established and well-studied cellular response to the stress and serves to relieve the stress and reinstate cellular homeostasis. It occurs in the endoplasmic reticulum (ER), responsible of properly folding and processing of secretory and transmembrane proteins. It is extremely sensitive to alteration in homeostasis caused by various internal or external stressors which leads to accumulation of misfolded or unfolded proteins in the ER lumen. The UPR works by restoring protein homeostasis in the ER, either through the boosting of protein-folding and degradation capability or by assuaging the demands for such effects, and can cause the activation of cell death if unable to do so. Cancer cells have adapted to gain advantage from the UPR and keeping the cell away from apoptosis and promoting survival, including survival of the cancer stem cells and evading the immune system. Several components of the UPR are overexpressed in a malignant cell and are responsible for resistance from various chemotherapy options and radiotherapy, which are also responsible for causing ER stress and activating the UPR. In this review, we discuss the various ways in which UPR can aid different cancers to survive and evade therapy and highlight recent research, which exploits the UPR to confer sensitivity to these cancer cells against various drugs and radiation.

Entities:  

Keywords:  Cancer Stem Cells; ER Stress; Immunotherapy; Radiation; UPR

Year:  2017        PMID: 29445586      PMCID: PMC5808614          DOI: 10.7150/oncm.22477

Source DB:  PubMed          Journal:  Oncomedicine        ISSN: 2206-6349


  117 in total

1.  EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin.

Authors:  Yukako Oda; Nobuko Hosokawa; Ikuo Wada; Kazuhiro Nagata
Journal:  Science       Date:  2003-02-28       Impact factor: 47.728

2.  Expression of ER stress and autophagy-related molecules in human non-small cell lung cancer and premalignant lesions.

Authors:  Kyoung Min Kim; Tack Keun Yu; Hyun Hee Chu; Ho Sung Park; Kyu Yun Jang; Woo Sung Moon; Myoung Jae Kang; Dong Geun Lee; Min Ho Kim; Ju Hyung Lee; Myoung Ja Chung
Journal:  Int J Cancer       Date:  2011-11-09       Impact factor: 7.396

3.  The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes.

Authors:  Rafal Bartoszewski; Joseph W Brewer; Andras Rab; David K Crossman; Sylwia Bartoszewska; Niren Kapoor; Cathy Fuller; James F Collawn; Zsuzsa Bebok
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

4.  3,3'-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5.

Authors:  Maen Abdelrahim; Kristen Newman; Kathy Vanderlaag; Ismael Samudio; Stephen Safe
Journal:  Carcinogenesis       Date:  2005-12-06       Impact factor: 4.944

5.  Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.

Authors:  Fortunato Ferrara; Daniela I Staquicini; Wouter H P Driessen; Sara D'Angelo; Andrey S Dobroff; Marc Barry; Lesley C Lomo; Fernanda I Staquicini; Marina Cardó-Vila; Suren Soghomonyan; Mian M Alauddin; Leo G Flores; Marco A Arap; Richard C Lauer; Paul Mathew; Eleni Efstathiou; Ana M Aparicio; Patricia Troncoso; Nora M Navone; Christopher J Logothetis; Serena Marchiò; Juri G Gelovani; Richard L Sidman; Renata Pasqualini; Wadih Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

6.  Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.

Authors:  Ghassan K Abou-Alfa; Philip Johnson; Jennifer J Knox; Marinela Capanu; Irina Davidenko; Juan Lacava; Thomas Leung; Bolorsukh Gansukh; Leonard B Saltz
Journal:  JAMA       Date:  2010-11-17       Impact factor: 56.272

7.  Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis.

Authors:  Masahiro Shuda; Nobuo Kondoh; Nobuo Imazeki; Kenji Tanaka; Tetsuya Okada; Kazutoshi Mori; Akiyuki Hada; Masaaki Arai; Toru Wakatsuki; Osamu Matsubara; Naoki Yamamoto; Mikio Yamamoto
Journal:  J Hepatol       Date:  2003-05       Impact factor: 25.083

8.  Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinib.

Authors:  Yi-He Ling; Tianhong Li; Roman Perez-Soler; Missak Haigentz
Journal:  Cancer Chemother Pharmacol       Date:  2009-01-08       Impact factor: 3.333

Review 9.  Cancer stem cells, hypoxia and metastasis.

Authors:  Richard P Hill; Delphine T Marie-Egyptienne; David W Hedley
Journal:  Semin Radiat Oncol       Date:  2009-04       Impact factor: 5.934

10.  Cell-extrinsic effects of tumor ER stress imprint myeloid dendritic cells and impair CD8⁺ T cell priming.

Authors:  Navin R Mahadevan; Veronika Anufreichik; Jeffrey J Rodvold; Kevin T Chiu; Homero Sepulveda; Maurizio Zanetti
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

View more
  9 in total

1.  Induction of endoplasmic reticulum stress by aminosteroid derivative RM-581 leads to tumor regression in PANC-1 xenograft model.

Authors:  Martin Perreault; René Maltais; Jenny Roy; Sylvain Picard; Ion Popa; Nicolas Bertrand; Donald Poirier
Journal:  Invest New Drugs       Date:  2018-07-30       Impact factor: 3.850

Review 2.  Insights into the role of endoplasmic reticulum stress in skin function and associated diseases.

Authors:  Kyungho Park; Sang Eun Lee; Kyong-Oh Shin; Yoshikazu Uchida
Journal:  FEBS J       Date:  2019-01       Impact factor: 5.542

3.  ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining "stemness".

Authors:  Patricia Dauer; Nikita S Sharma; Vineet K Gupta; Brittany Durden; Roey Hadad; Santanu Banerjee; Vikas Dudeja; Ashok Saluja; Sulagna Banerjee
Journal:  Cell Death Dis       Date:  2019-02-12       Impact factor: 8.469

4.  Targeting valosin-containing protein enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma.

Authors:  Hui Luo; Hengli Song; Ronghu Mao; Qiang Gao; Zhuo Feng; Nan Wang; Shuai Song; Ruidi Jiao; Peizan Ni; Hong Ge
Journal:  Cancer Sci       Date:  2019-09-13       Impact factor: 6.716

5.  The Isoxazole Derivative of Usnic Acid Induces an ER Stress Response in Breast Cancer Cells That Leads to Paraptosis-like Cell Death.

Authors:  Agnieszka Pyrczak-Felczykowska; Tristan A Reekie; Marcin Jąkalski; Aleksandra Hać; Marcelina Malinowska; Anna Pawlik; Kamil Ryś; Beata Guzow-Krzemińska; Anna Herman-Antosiewicz
Journal:  Int J Mol Sci       Date:  2022-02-04       Impact factor: 5.923

6.  Downregulation of Low-density lipoprotein receptor-related protein 1B (LRP1B) inhibits the progression of hepatocellular carcinoma cells by activating the endoplasmic reticulum stress signaling pathway.

Authors:  Zili Zhen; Zhemin Shen; Peilong Sun
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 7.  Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic.

Authors:  Luni Emdad; Praveen Bhoopathi; Sarmistha Talukdar; Anjan K Pradhan; Devanand Sarkar; Xiang-Yang Wang; Swadesh K Das; Paul B Fisher
Journal:  Semin Cancer Biol       Date:  2019-07-26       Impact factor: 15.707

Review 8.  Mutant p53 and Cellular Stress Pathways: A Criminal Alliance That Promotes Cancer Progression.

Authors:  Gabriella D'Orazi; Mara Cirone
Journal:  Cancers (Basel)       Date:  2019-05-02       Impact factor: 6.639

9.  Therapeutic Potential of (-)-Agelamide D, a Diterpene Alkaloid from the Marine Sponge Agelas sp., as a Natural Radiosensitizer in Hepatocellular Carcinoma Models.

Authors:  Changhoon Choi; Yeonwoo Cho; Arang Son; Sung-Won Shin; Yeon-Ju Lee; Hee Chul Park
Journal:  Mar Drugs       Date:  2020-09-29       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.